Table 6.

The comparison of irisin, NRG-4 and FGF21 according to gender subgroups

	Metabolic phenotype									Gender
	Metabolic unhealthy			Metabolic healthy			Total sample			Male			Female
	Male median (min-max)	Female median (min-max)	p	Male median (min-max)	Female median (min-max)	p	Male median (min-max)	Female median (min-max)	p	Metabolic healthy median (min-max)	Metabolic unhealthy median (min-max)	p	Metabolic healthy median (min-max)	Metabolic unhealthy median (min-max)	p
İrisin (conc.pg/ml)	236.8 (19.1–2048)	119.9 (10.1–3364)	0.36	143.7 (41.5–1653)	158.1(3.3–2666)	0.52	190.2 (19.1–2048)	152.3 (3.3–3364)	0.22	143.7 (41.5–1653)	236.8 (19.1–2048)	0.86	158.1 (3.3–2666)	119.9 (10.1–3364)	0.61
NRG-4 (ng/ml)	1.09 (0.3–4.2)	0.7 (0.09–10.2)	0.45	0.87 (0.2–1.89)	0.69 (0.04–4.5)	0.98	0.9 (0.2–4.2)	0.7 (0.04–10.2)	0.47	0.9 (0.2–1.8)	1.09 (0.3–4.2)	0.44	0.7 (0.04–4.5)	0.8 (0.09–10.2)	0.59
FGF-21 (conc.pg/ml)	25.4 (0.4–291.3)	25.4 (0.4–19.3)	0.94	43.8 (4.6–182.2)	26.5 (1.8–461.3)	0.95	32.2 (3.5–182.2)	25.6 (0.4–461.8)	0.93	43.8 (4.6–182.2	26.9 (3.5–110.6)	0.35	26.5 (1.8–461.8)	25.4 (0.4–291.3)	0.49